Literature DB >> 29717371

Visceral leishmaniasis from a non-endemic Himalayan region of Nepal.

Mitesh Shrestha1, Basu Dev Pandey2, Jyoti Maharjan1, Shyam Prakash Dumre3, Prakash Nidhi Tiwari4, Krishna Das Manandhar5, Sher Bahadur Pun6, Kishor Pandey7,8.   

Abstract

Visceral leishmaniasis (VL) is endemic to the southern plains of Nepal. Here, we report the first case of VL from a non-endemic Himalayan region of Nepal. The patient presented with a history of high-grade fever, splenomegaly, and anemia but had not traveled to a VL-endemic region. Visceral leishmaniasis was diagnosed following microscopic detection of the Leishmania species amastigote in a bone marrow aspirate, positive result for the rK39 test, and further validation by nested polymerase chain reaction (PCR). The patient was treated with 5 mg/kg liposomal amphotericin B and was clinically improved upon discharge. Our result suggests that VL is expanding towards non-endemic regions of Nepal, and it should therefore be considered that VL surveillance systems be strengthened, particularly for non-program districts and VL be included as a differential diagnosis in febrile illnesses.

Entities:  

Keywords:  Himalayan region; Nepal; PCR; Visceral leishmaniasis

Mesh:

Substances:

Year:  2018        PMID: 29717371     DOI: 10.1007/s00436-018-5887-6

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  13 in total

1.  Case report: Expansion of visceral leishmaniasis to the western hilly part of Nepal.

Authors:  Basu Dev Pandey; Sher Bahadur Pun; Osamu Kaneko; Kishor Pandey; Kenji Hirayama
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

2.  Kala-Azar at high altitude.

Authors:  Sanjay K Mahajan; Prem Machhan; Anil Kanga; Surinder Thakur; Ashok Sharma; Bhupal Singh Prasher; Lal Singh Pal
Journal:  J Commun Dis       Date:  2004-06

Review 3.  Leishmaniasis. Public health aspects and control.

Authors:  P Desjeux
Journal:  Clin Dermatol       Date:  1996 Sep-Oct       Impact factor: 3.541

4.  A nested-PCR-based schizodeme method for identifying Leishmania kinetoplast minicircle classes directly from clinical samples and its application to the study of the epidemiology of Leishmania tropica in Pakistan.

Authors:  H A Noyes; H Reyburn; J W Bailey; D Smith
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

5.  Diagnosis of visceral leishmaniasis by polymerase chain reaction of DNA extracted from Giemsa's solution-stained slides.

Authors:  Kishor Pandey; Basu Dev Pandey; Arun Kumar Mallik; Osamu Kaneko; Haruki Uemura; Hiroji Kanbara; Tetsuo Yanagi; Kenji Hirayama
Journal:  Parasitol Res       Date:  2010-05-25       Impact factor: 2.289

6.  American visceral leishmaniasis (kala-azar) in hospitalized children from an endemic area.

Authors:  Luís C Rey; Ceci V Martins; Hildenia B Ribeiro; Aldo A M Lima
Journal:  J Pediatr (Rio J)       Date:  2005 Jan-Feb       Impact factor: 2.197

7.  Conflict and kala-azar: determinants of adverse outcomes of kala-azar among patients in southern Sudan.

Authors:  Simon Collin; Robert Davidson; Koert Ritmeijer; Kees Keus; Yosef Melaku; Sammy Kipngetich; Clive Davies
Journal:  Clin Infect Dis       Date:  2004-02-12       Impact factor: 9.079

8.  Leishmaniasis worldwide and global estimates of its incidence.

Authors:  Jorge Alvar; Iván D Vélez; Caryn Bern; Mercé Herrero; Philippe Desjeux; Jorge Cano; Jean Jannin; Margriet den Boer
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

9.  Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria.

Authors:  Peter J Hotez; David H Molyneux; Alan Fenwick; Eric Ottesen; Sonia Ehrlich Sachs; Jeffrey D Sachs
Journal:  PLoS Med       Date:  2006-01       Impact factor: 11.069

10.  Transmission of Leishmania donovani in the Hills of Eastern Nepal, an Outbreak Investigation in Okhaldhunga and Bhojpur Districts.

Authors:  Bart Ostyn; Surendra Uranw; Narayan Raj Bhattarai; Murari L Das; Keshav Rai; Katrien Tersago; Yubraj Pokhrel; Lies Durnez; Baburam Marasini; Gert Van der Auwera; Jean-Claude Dujardin; Marc Coosemans; Daniel Argaw; Marleen Boelaert; Suman Rijal
Journal:  PLoS Negl Trop Dis       Date:  2015-08-07
View more
  4 in total

1.  Validation of SYBR green I based closed tube loop mediated isothermal amplification (LAMP) assay and simplified direct-blood-lysis (DBL)-LAMP assay for diagnosis of visceral leishmaniasis (VL).

Authors:  Keerti Kaumudee Dixit; Sandeep Verma; Om Prakash Singh; Dharmendra Singh; Akhil Pratap Singh; Ratan Gupta; Narendra Singh Negi; Pradeep Das; Shyam Sundar; Ruchi Singh; Poonam Salotra
Journal:  PLoS Negl Trop Dis       Date:  2018-11-15

2.  A case report of visceral leishmaniasis and malaria co-infection with pancytopenia and splenomegaly - a diagnostic challenge.

Authors:  Pragya Gautam Ghimire; Prasanna Ghimire; Jyoti Adhikari; Anurag Chapagain
Journal:  BMC Infect Dis       Date:  2019-10-15       Impact factor: 3.090

3.  A multicentric evaluation of dipstick test for serodiagnosis of visceral leishmaniasis in India, Nepal, Sri Lanka, Brazil, Ethiopia and Spain.

Authors:  Sarfaraz Ahmad Ejazi; Sneha Ghosh; Samiran Saha; Somsubhra Thakur Choudhury; Anirban Bhattacharyya; Mitali Chatterjee; Krishna Pandey; V N R Das; Pradeep Das; Mehebubar Rahaman; Rama Prosad Goswami; Keshav Rai; Basudha Khanal; Narayan Raj Bhattarai; Bhagya Deepachandi; Yamuna Deepani Siriwardana; Nadira D Karunaweera; Maria Edileuza Felinto deBrito; Yara de Miranda Gomes; Mineo Nakazawa; Carlos Henrique Nery Costa; Emebet Adem; Arega Yeshanew; Roma Melkamu; Helina Fikre; Zewdu Hurissa; Ermias Diro; Eugenia Carrillo; Javier Moreno; Nahid Ali
Journal:  Sci Rep       Date:  2019-07-09       Impact factor: 4.379

4.  Recuperating Biopharmaceutical Aspects of Amphotericin B and Paromomycin Using a Chitosan Functionalized Nanocarrier via Oral Route for Enhanced Anti-leishmanial Activity.

Authors:  Shabi Parvez; Ganesh Yadagiri; Archana Karole; Om Prakash Singh; Anurag Verma; Shyam Sundar; Shyam Lal Mudavath
Journal:  Front Cell Infect Microbiol       Date:  2020-10-15       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.